Managed care for AIDS patients: is bigger better?

Area of Science:

• Health Services Research
• Public Health
• Infectious Disease Epidemiology

Background:

• Medicaid is a primary funder of AIDS-related healthcare in the U.S.
• Managed care programs are increasingly replacing traditional fee-for-service Medicaid models to control costs.
• This shift necessitates evaluating the impact on care quality for vulnerable populations like AIDS patients.

Purpose of the Study:

• To evaluate how patient volume at clinical sites affects the quality of care for individuals with Acquired Immunodeficiency Syndrome (AIDS) within a Medicaid managed care framework.
• To identify potential disparities in care quality related to provider caseloads.

Main Methods:

• A cohort study analyzed Acquired Immunodeficiency Syndrome (AIDS) patients enrolled in Maryland's Medicaid managed care program between July 1997 and December 1998.
• Patient records were reviewed, supplemented with data from the state's HIV/AIDS surveillance database.
• Quality indicators were assessed by comparing clinical sites with low (1-15), medium (16-100), and high (101-500) annual Medicaid AIDS patient volumes.

Main Results:

• High-volume clinical sites demonstrated superior performance across nearly all examined quality indicators compared to low- and medium-volume sites.
• Few performance differences were noted between low- and medium-volume sites.
• Despite better quality adherence, high-volume sites reported a higher number of patient deaths, even after adjusting for confounders.

Conclusions:

• Significant variations in healthcare quality for Acquired Immunodeficiency Syndrome (AIDS) patients exist within statewide Medicaid managed care systems.
• High-volume sites align more closely with Public Health Service guidelines, indicating their potential to deliver superior quality AIDS care.
• These findings underscore the importance of patient volume as a determinant of care quality in managed healthcare settings for complex conditions.